SAB Biotherapeutics, Inc. (SABS) — Analyst estimates
Consensus analyst estimates for SAB Biotherapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 125K | -0.27 | 1 |
| 2027 | 0 | -0.13 | 1 |
| 2028 | 8.42M | -0.72 | 8 |
| 2029 | 99.96M | -0.47 | 6 |
| 2030 | 264.38M | 0.1 | 6 |
Consensus analyst estimates by fiscal year.